Lv1
80 积分 2022-08-08 加入
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer
1个月前
已完结
The Value of PSMA-RADS Version 2.0 in the Assessment of Pulmonary Metastases in Patients With Prostate Cancer and the Improvement of Differential Diagnosis Efficiency by PSMA PET/CT Parameters
1个月前
已完结
PROMISE V2 — something new, something old and something borrowed
1个月前
已完结
PSMA-RADS to improve evaluation and management of prostate cancer
1个月前
已完结
Reproducibility and Accuracy of the PRIMARY Score on PSMA PET and of PI-RADS on Multiparametric MRI for Prostate Cancer Diagnosis Within a Real-World Database
2个月前
已完结
The impact of integrating PRIMARY score or SUVmax with MRI-based risk models for the detection of clinically significant prostate cancer
2个月前
已完结
Avoiding unnecessary biopsy: the combination of PRIMARY score with prostate-specific antigen density for prostate biopsy decision
2个月前
已完结
Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
3个月前
已完结
Positron Emission Tomography Response Criteria in Solid Tumors (PERCIST)
3个月前
已关闭
MRI and PSMA PET/CT of Biochemical Recurrence of Prostate Cancer
3个月前
已完结
皖公网安备34019202002308
